GREAT Lecture1 Epid Study Design Handout

83
8/13/2019 GREAT Lecture1 Epid Study Design Handout http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 1/83  GREAT Network Training Program 2013 Lecture 1 Epidemiology and Study Designs Instructor: Dr. Jason Pole

Transcript of GREAT Lecture1 Epid Study Design Handout

Page 1: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 1/83

 

GREAT Network Training Program

2013 

Lecture 1Epidemiology and Study Designs

Instructor: Dr. Jason Pole

Page 2: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 2/83

GREAT Network Epidemiology and Surveillance Program

Epidemiology and Study Designs Lecture

Presented by Jason D. Pole, PhD

Objectives:

By the end of this session, participants will be able to define and distinguish between the

following study designs: cohort, randomized control trial, case control, prospective, retrospectiveand cross-sectional. Participants will also be able to define the following terms in relation to

these study designs: population perspective, clinical perspective, incidence, prevalence,confounding, causation, risk, bias, odds ratio, relative risk and person-years.

Background:

Before the lecture please read the following:

(1) Chapter 4 - Epidemiology An Introduction by Kenneth J. Rothman, 2002, OUP

(2) Chapter 11 - Epidemiology An Introduction by Kenneth J. Rothman, 2002, OUP

(3) Priftis KN, D. Mermiri, A Papadopoulou, M. Papadopoulos, A Fretzayas and E Lagona.Asthma Symptoms and Bronchial Reactivity in School Children Sensitized to Food Allergens in

Infancy. Journal of Asthma, 2008, 45:590-595.

(4) Kiechl-Kohlendorfer U, E Horak, W Mueller, R Strobi, C Haberland, F-M Fink, MSchwaiger, K-H Gutenberger, H Reich, D Meraner and S Kiechl. Neonatal characteristics andrisk of atopic asthma in schoolchildren: results from a large prospective birth-cohort study. Acta

Paediatrica, 2007, 96:1606-1610.

The information in the two chapters will largely be covered as part of the lecture, but youwill be able to follow the lecture more easily if you have read the chapters a head of time. You

only need to read the abstract, introduction and methods sections of the two papers. We will

discuss these papers during the lecture. 

Page 3: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 3/83

 

LECTURE POWERPOINT

PRESENTATION

Page 4: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 4/83

GREAT Network:

Epidemiology and Surveillance Program

Epidemiology Methods Lecture

Jason D. Pole, PhD

Pediatric Oncology Group of Ontario

 [email protected]

Page 5: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 5/83

Outline

• Epidemiology Perspectives

• Random Pieces (well, not exactly random)

• Study Designs

Page 6: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 6/83

Epidemiology:

Population versus Clinical• Population Epidemiology

 –  study of distribution and determinants of disease in groups of

people

 –  Historical focus on biological and social determinants of health

 –  Now includes health service and health policy

• Clinical Epidemiology

 –  epidemiological methods and biostatistics applied to research in

health care practice –  focus on

• evaluating diagnostic value of new tests

• evaluating value of treatments and procedures

Page 7: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 7/83

Distribution

• Person

 –  age, gender, race, socio-economic status etc.

• Place

 –  census tract, county, province, country, urban / rural etc.

• Time

 –  year, season etc.

Page 8: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 8/83

Example: Mystery Epidemic

Socio-Economic

Class   N

Death

Rate (%)   N

Death

Rate (%)   N

Death

Rate (%)   N

Death

Rate (%)

High 173 66.5 144 3.5 5 0 322 37.3Middle 160 91.9 93 16.1 24 0 277 58.5

Low 454 87.9 179 45.3 76 71.1 709 75.3

Unknown 875 78.4 23 8.7 0 -- 898 76.6

Total 1662 81 439 23.5 105 51.4 2206 68.2

 Adult Males Adult Females Children Total

Note: N refers to the total numbers of persons in each strata

Questions:

1. Describe the epidemiological features of this episode.2. Based on the descriptive characteristics:

formulate a hypothesis concerning the etiology of this episode.

Page 9: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 9/83

Random Pieces

• Incidence Rate

• Prevalence• Person-Time

• Causation

• Relative Risk• Odds Ratio

• Bias

• Confounding

Page 10: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 10/83

Incidence Rate

• Number of new cases of an outcome that occurs during

a specified period of time in a defined population at risk

for developing the outcome divided by the number of

persons in the population at risk

• Time (required for a rate)

• New cases (numerator)

• Specified population at risk (denominator)

 –  those in the denominator must have potential to be counted in numerator 

• Incidence of Asthma in Ontario:

 –  10 per 1000 population aged 0-39 years in 2001

Page 11: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 11/83

Prevalence

• Proportion of persons in a defined population who had

the outcome at some point during the time period

• Proportion and not a rate!

• Number of existing cases (numerator)

• Number of persons in specified population (denominator)

• Prevalence of Asthma in Ontario:

 –  58 per 1000 population aged 0-39 years in 2001 (5.8 %)

Page 12: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 12/83

Person-Time

• Often rates are described not per person but for some

unit of person time

• Useful when people are followed for different periods of

time

• Implicit assumption that observing 10 persons for 10

years is equivalent to observing 100 persons for 1 year 

Page 13: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 13/83

Causation

• Strength

• Consistency• Specificity

• Temporality

• Biological Gradient (dose response)• Plausibility

• Coherence

• Experimental Evidence

•  Analogy (other possible explanations)

Page 14: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 14/83

Relative Risk

• RR = incidence in group A / incidence in group B

• RR is a ratio so dimensionless (units cancel)

• Required to make clear which groups are beingcompared (it is relative)

Page 15: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 15/83

Relative Risk Calculation

Outcome Develops Outcome Didn’t Develop

Group A (often exposed) a b

Group B (often nonexposed) c d

Iexp = a/(a+b)

Inonexp = c/(c+d)

RR = Iexp / Inonexp

Those who are exposed are *.* times as likely to develop the outcome

compared to those who are not exposed.

Page 16: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 16/83

Relative Risk Interpretation

• RR = 1

 –  risk in group A is same as in group B

 –  no association

• RR > 1

 –  risk in group A is larger compared to group B

 –  positive association

 –  larger the RR the stronger the association

 –  does not infer causation

• RR < 1

 –  risk in group A is smaller compared to group B

 –  negative association

 –  smaller the RR the stronger the negative association

Page 17: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 17/83

Odds Ratio

•  Approximates the RR if the disease is rare in the

unexposed population (probability of event is < 5%)

• OR = odds that those with outcome were exposed / odds

that those without the outcome were exposed

• OR is a ratio so dimensionless (units cancel)

Page 18: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 18/83

Odds Ratio Calculation

Outcome Develops

Cases

Outcome Didn’t Develop

Controls

Exposed a b

Nonexposed c d

Odds of Exposurecase = a/(a+c) = a/c

Odds of Exposurecontrols = b/(b+d) = b/d

OR = Odds of Expcase / Odds of Expcontrol = (a/c)(b/d) = ad/bc

Those who develop the outcome are *.* times as likely to be exposed

compared to those who did not develop the outcome.

Page 19: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 19/83

Bias

• Systematic error in design or conduct that results in a

distortion of the estimate of association

• Three main categories:

 –  selection

• design stage

• systematic inclusion or exclusion of participants by any mechanism

 –  information

• study execution stage

• systematic difference in measurement

 –  confounding

See: Choi BC and AL Noseworthy. 1992. Classification, direction, and prevention of bias in

epidemiological research. JOM 34:3 pg 265-271

Page 20: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 20/83

Confounding

• Specific type of bias

• Distortion of the association of interest by a third variable

• Confounder  –  can not be in causal pathway

 –  must be associated with both the exposure and outcome

OutcomeExposure

Confounder 

Page 21: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 21/83

Pause…

Page 22: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 22/83

Epidemiology Study Designs

• Experimental Studies

 –  Randomized Control Trials

 –  Community Trials

• Observational Studies

 –  Cohort Study

 –  Case-Control Study –  Cross-Sectional Study

 –  Ecological Study

Page 23: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 23/83

Randomized Controlled Trials

• Features

 –  random assignment of subjects to 2 or more groups

 –  one group acts as a ‘control’ –  other groups are provided ‘new’ treatment

 –  groups followed over time for rates of outcome

 –  the groups only differ by the treatment

 –  temporality established

• Regarded as most scientifically rigorous method

• RCTs generally test efficacy not effectiveness!

 –  analyze as randomized!

Page 24: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 24/83

RCT Design

Eligible

Subjects

Treatment GroupOutcome Present

Outcome Not Present

Control Group

Outcome Present

Outcome Not Present

Randomization

Time

Page 25: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 25/83

RCT Advantages & Disadvantages

•  Advantages

 –  randomization

 –  concurrent control group

 –  blind assessment

• subject, outcome assessor, treatment administrator 

• Disadvantages

 –  expensive (time, money, people)

 –  potential ethical issues –  issues with representativeness

 –  can’t be used to study harmful exposures

Page 26: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 26/83

Pause…

Page 27: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 27/83

Cohort Design

• Features

 –  starts with a subject pool that does not have outcome

 –  subjects self-select into exposure group

 –  entire subject pool followed over time for rates of outcome

 –  temporality established

• Researcher has no control over changes in exposure

• Open versus Closed Cohort

•  Among observational studies, they are the gold standard

Page 28: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 28/83

Cohort Design

Eligible

Subjects

Exposed GroupOutcome Present

Outcome Not Present

Unexposed Group

Outcome Present

Outcome Not Present

Self Selection

Time

Page 29: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 29/83

Cohort Advantages & Disadvantages

•  Advantages –  minimizes bias

• recall and information –  prospective - temporality

 –  limited ethical issues (you don’t have to withhold treatment)

 –  can study several outcomes in same study

• Disadvantages –  expensive (time, money, people)

 –  potential for confounding –  loss of follow-up

 –  not good for rare outcomes

 –  sample size of exposed and unexposed group is not controlled

Page 30: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 30/83

Paper Discussion: Kiechl-Khlendorfer et al.

• What is the purpose / objective of the study?

• What type of study design has been used?

• Does it make sense to do this study given the literature / past studies (i.e. isthere a clear rationale, or gap in the literature, to justify this study?)

• How is the study population defined?• What criteria were used to define the study sample?

• Did the authors address the size of the sample needed to show the desiredresults?

• Did the authors obtain the consent of participants? If so, how?

• Was it clear how the participants were followed and how long they neededto be followed?

• What was the nature of the exposed and unexposed groups?

• What was the health outcome and how was it defined / measured?

• Did the authors take into account any potential cofounders? If so, how?• Did the authors approach the analysis in a way that would answer the

research question?

• What types of bias might be present in the study?

• What are the advantages of using this study design?

•  Are there alternative study designs to address the question?

Page 31: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 31/83

Pause…

Page 32: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 32/83

Case-Control Study

• Features

 –  start with all cases in population of interest

 –  identify a set of controls

• from the same population that gave rise to the cases

 –  retrospectively assess exposure

• Selection of control group can be problematic

• Potential to introduce bias

Page 33: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 33/83

Case-Control Design

EligibleSubjects

Cases(those with outcome)

Exposed

Not Exposed

Controls

(those without outcome)

Exposed

Not Exposed

Time

Present

Case Control

Page 34: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 34/83

Case-Control

 Advantages & Disadvantages•  Advantages

 –  relatively cheap to conduct

 –  concurrent control group

• the investigator controls the size of the two groups

 –  good for rare outcomes

• Disadvantages

 –  difficult to obtain retrospective exposure information

• potential to introduce bias

 –  difficult to select appropriate control group

• potential to introduce bias

Page 35: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 35/83

Paper Discussion: Priftis et al.• What is the purpose / objective of the study?

• What type of study design has been used?

• Does it make sense to do this study given the literature / past studies (i.e. isthere a clear rationale, or gap in the literature, to justify this study?)

• How is the study population defined?• What criteria were used to define the study sample?

• Did the authors address the size of the sample needed to show the desiredresults?

• Did the authors obtain the consent of participants? If so, how?

• What were the outcome groups and how was the outcomedefined/measured?

• What was the nature of the exposed and unexposed groups?

• Did the authors take into account any potential cofounders? If so, how?

• Did the authors approach the analysis in a way that would answer theresearch question?

• What types of bias might be present in the study?

• What are the advantages of using this study design?

•  Are there alternative study designs to address the question?

Page 36: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 36/83

 

READING MATERIALS

This article was downloaded by: [University of Toronto]

Page 37: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 37/83

 

PLEASE SCROLL DOWN FOR ARTICLE

This article was downloaded by: [University of Toronto] On: 15 October 2008 Access details: Access Details: [subscription number 793222078] Publisher Informa Healthcare Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House,

37-41 Mortimer Street, London W1T 3JH, UK

Journal of AsthmaPublication details, including instructions for authors and subscription information:http://www.informaworld.com/smpp/title~content=t713597262

Asthma Symptoms and Bronchial Reactivity in School Children Sensitized toFood Allergens in Infancy

Kostas N. Priftisa

; Despina Mermiria

; Athina Papadopouloua

; Marios Papadopoulosa

; Andrew Fretzayasb

;Evagelia Lagona c

a Department of Allergy-Pneumonology, Penteli Children's Hospital, Athens, Greece b Third Department ofPediatrics, Attikon Hospital, Athens University Medical School, Athens, Greece c First Department ofPediatrics, “Aghia Sophia” Children's Hospital, Athens University Medical School, Athens, Greece

Online Publication Date: 01 September 2008

To cite this Article Priftis, Kostas N., Mermiri, Despina, Papadopoulou, Athina, Papadopoulos, Marios, Fretzayas, Andrew and Lagona,Evagelia(2008)'Asthma Symptoms and Bronchial Reactivity in School Children Sensitized to Food Allergens in Infancy',Journal ofAsthma,45:7,590 — 595

To link to this Article DOI 10.1080/02770900802032941

URL http://dx.doi.org/10.1080/02770900802032941

Full terms and conditions of use: http://www.informaworld.com/terms-and-conditions-of-access.pdf

This article may be used for research, teaching and private study purposes. Any substantial orsystematic reproduction, re-distribution, re-selling, loan or sub-licensing, systematic supply ordistribution in any form to anyone is expressly forbidden.

The publisher does not give any warranty express or implied or make any representation that the contentswill be complete or accurate or up to date. The accuracy of any instructions, formulae and drug doses

should be independently verified with primary sources. The publisher shall not be liable for any loss,actions, claims, proceedings, demand or costs or damages whatsoever or howsoever caused arising directlyor indirectly in connection with or arising out of the use of this material.

 Journal of Asthma, 45:590–595, 2008Copyright   C 2008 Informa Healthcare USA, Inc.

Page 38: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 38/83

Copyright  2008 Informa Healthcare USA, Inc.ISSN: 0277-0903 print / 1532-4303 onlineDOI: 10.1080/02770900802032941

ORIGINAL ARTICLE

Asthma Symptoms and Bronchial Reactivity in School Children Sensitizedto Food Allergens in Infancy

KOSTAS N. PRIFTIS,1 DESPINA MERMIRI,1 ATHINA PAPADOPOULOU,1 MARIOS PAPADOPOULOS,1

ANDREW FRETZAYAS,2AND EVAGELIA LAGONA

3

1 Department of Allergy-Pneumonology, Penteli Children’s Hospital, Athens, Greece2Third Department of Pediatrics, Attikon Hospital, Athens University Medical School, Athens, Greece

3First Department of Pediatrics, “Aghia Sophia” Children’s Hospital, Athens University Medical School, Athens, Greece

Food allergy in infancy usually disappears but is followed primarily by respiratory allergy. We hypothesized that children allergic to common food

allergens in infancy are at increased risk of wheezing illness and bronchial hyperresponsiveness during school age. In a c ase-control study 69 children

7.2 to 13.3 years of age allergic to egg (N  =  60) and/or fish (N =  29) in early life (first 3 years) who attended our allergy outpatient clinic were

recruited. They received follow-up for 1 year and were evaluated by parental questionnaire, skin prick testing, spirometry, and metacholine bronchial

challenge. Another 154 children (70 sensitized to inhaled allergens) recruited selectively from a general population sample with no history of food

allergy during their first 3 years served as control subjects. Twenty-three children (38.3%) maintained their sensitization to egg and 19 (65.5%) to fish;

the prevalence of sensitization to ≥1 inhaled allergen(s) increased from 59.4% to 71% during childhood. Current asthma symptoms were reported

more frequently in the study group than in either control groups, sensitized to inhaled allergens and non-sensitized. Children of the study group

showed a significantly increased frequency of positive response to metacholine bronchial challenge compared to the control group as a whole; thedifference was statistically indicative when study groups separately were compared to the sensitized control subjects. Multivariate logistic regression

analysis showed that bronchial hyperresponsiveness, as well as reported current asthma symptoms were associated with early wheezing and early

sensitization to inhaled allergensbut not with atopicdermatitis in infancy or persistence of eggor fishallergy. Childrenallergicto egg or fishin infancy

are at increased risk for wheezing illness and hyperactive airways in school age; asthma and bronchial hyperresponsiveness development is mostly

determined by wheezing and senzitization to inhaled allergens in early life regardless of atopic dermatitis in infancy or retention of food allergy.

Keywords   allergic march, asthma, atopic dermatitis, bronchial hyperresponsiveness, food allergy, inhaled allergens

INTRODUCTION

During the last few decades, a worldwide phenomenonof increase in the prevalence of asthma in parallel to otherallergic conditions such as food allergy, rhinitis, and eczemahas been consistently observed (1, 2). Atopic dermatitis andfood allergy often begin in infancy and there appears to bean onward trend that leads to asthma and allergic rhinitisin school age or early adulthood (3). Prevention strategieshave mainly targeted the interruption of the allergic trend (4);therefore, knowledge of specific predictors in early infancy isa prerequisite if preventive intervention is being considered.

Sensitization to hen’s egg in early life has been proposed asa predictor of subsequent sensitization to inhalant allergensthat in itself constitutes a strong determinant of asthma (5, 6).Early onset of immunoglobulin (IgE)-mediated food allergy,especially if associated with atopic dermatitis, indicates a Th2

dominant lymphocytic response pattern and a cytokine pro-

of life demonstrating a clear temporal relationship with the

introduction of these foods intothe children’s diet. Over time,most food allergy is lost, although the possibility of suchloss depends on the individual child and the specific foodallergen. In contrast to cow’s milkand egg, allergies to fishareusually not outgrown (8). It is not clear if infants who presentwith food allergies with different natural history would tenddifferently to develop asthma at school age.

The mechanisms that predispose children with food allergyto develop asthma at a later age remain poorly understood.It is speculated that the immunologic basis of specific or-

gan syndromessuch as allergic rhinitis and asthma actuallyresults from a systemic dysregulationof immunity (9, 10);eczema and at a later age hyperreactive airways could bemanifestations of different target organs within the frame of the same systemic disease. Most studies that address this is-sue are observational and focus on the so-called “allergic

h ” i h li i l i f h b i i h

 D o w nl

 o ad

 ed 

 B y : [

 U ni

 v e r si

 t y 

 of 

 T o r o n t o] 

 A t : 21

 :20 1

 O c t ob

 e r 2008

FOOD ALLERGY, ASTHMA AND BRONCHIAL REACTIVITY 591

Page 39: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 39/83

TABLE 1.—General characteristics of the study population (study group and two

control groups).

Study group

N = 69

Sensitisedcontrols

N = 70

Non-sesnsitisedcontrols

N = 84

Male (%) 52 (75.4) 44 (62.8) 50 (59.5)Median age, years (range) 9.9 (7.2–13.3) 10.3 (8.0–13.5) 10.0 (7.5–13.1)Atopic family history (%) 41 (59.4)∗ 35 (50.0)¶ 21 (25.0)Passive smoking (%) 45 (65.2) 46 (65.7) 56 (66.7)Cent ral house heat ing (%) 59 (85.5) 56 (80.0) 67 (79.8)Lifetime asthma symptoms (%) 38 (55.1)∗# 20 (28.5)¶ 9 (10.7)Current asthma symptoms (%) 30 (43.5)∗# 17 (24.3)¶ 5 (5.9)

Lifetime chronic rhinitis (%) 27 (39.1)§ 23 (32.8) 19 (22.6)

Current chronic rhinitis (%) 20 (29.0)§ 21 (30.0)§ 13 (15.5)Lifetime atopic dermatitis (%) 38 (55.1)∗# 20 (28.5) 13 (15.5)Current atopic dermatitis (%) 7 (10.1)# 19 (27.1) 8 (9.5)

∗In comparison to non-sensitised controls:  p < 0.001.#In comparison to sensitised controls:  p < 0.01.¶In comparison to non-sensitised controls:  p < 0.01.§In comparison to non-sensitised controls:  p < 0.05.

PATIENTS AND METHODS

Study population

The present case-control study evaluated three groups of children (Table 1). The study group consisted of 69 school

age children who presented to our outpatient allergy clinicduring the first 3 years of life for a variety of symptoms fromJanuary 1995 until the end of 1998. The diagnosis of foodallergy was based on a positive skin prick test (SPT) resultor a positive serum-specific IgE test to hen’s egg or/and fish(>0.35 IU/mL), a well-documented history of reaction torelevant food(s), and, in 13 cases, on immediate symptomsafter open challenge with suspected food. Sixty children wereallergic to hen’s egg (egg white and yolk) and 29 to fish (20were sensitized to both). Open food challenges were also

performed when appropriate to investigate development of tolerance (14, 15).

Study inclusion criteria were (1) symptomatic sensitiza-tion to hen’s egg and/or fish during the first 3 years of life,(2) age on recruitment over 7 years, and (3) ability to per-form reproduciblespirometry according to the standards of the American Thoracic Society (16). Children with diag-nosed or suspected cystic fibrosis, primary ciliary dyskinesia,myoskeletal abnormalities, immunodeficiency, and history of bronchopulmonary dysplasia were excluded.

Study Design

Follow-up and review of patients and controls were per-formed between February 2003 and September 2005. A de-tailed medical and socialhistory, physical examination, SPTs,spirometry, methacholine challenge test (MCT) when feasi-

expiratory volume in one second (FEV1), and forced expi-ratory flow at 50% FVC (FEF50) were recorded. Spirometrywas deferred if the child had a respiratory tract infectionwithin 3 weeks or had used a bronchodilator within 12 hoursof assessment for study purposes. Values were expressed aspercentage of predicted for gender and height (17).

Assessment of BHR was performed only when FEV1 val-ues were more than 70% of the predicted value. Childrenunderwent MCT according to the American Thoracic Soci-ety guidelines (18). The short protocol of five tidal breathswas performed. The procedure was discontinued if FEV1

decreased by more than 20% of baseline values or whena 16 mg/mL concentration had been administered. Asthmamedication such as short- and long-acting beta2-agonists,

leukotriene modifiers, or chromones were withheld for 24to 48 hours before testing; anti-histamines were also discon-tinued for an appropriate period depending on the pharma-cokinetic characteristics of the various medications. Inhaledcorticosteroids were continued as prescribed. Spirometry andMCT were performed during asymptomatic periods (a min-imum of 6 weeks after resolution of any acute respiratorysymptomatology), between 9  A.M. and 1  P.M.

Atopic status was assessed by skin-prick testing (SPT).They were performed on the volar aspects of the forearm

with eight common standardized inhaled allergen extractssuch as house dust mites ( Dermatophagoides pteronyssinus,

 Dermatophagoides farinae), Alternaria alternata, olive tree,mixed grasses and Parietaria officinalis pollens, cat and dogdander; another battery of five common food standardized al-lergenextracts,i.e., cow’s milk, hen’s egg, mixed cereals, fish,and mixed nuts, was tested (SoluprickTM, ALK, Hørsholm,Denmark). Histamine dihydrochloride 10 mg.mL−1 was usedas the positive and 50% glycerol as the negative control. Theprick tests were performed according to the instructions of 

the European Academy of Allergy and Clinical Immunology(EAACI) (19). Children were considered to be sensitized if a palpable wheal reaction to any allergen, calculated as thesum of the longest and the midpoint orthogonal diametersdivided by two, was ≥3 mm larger than the negative control.

Children that belonged to the study group were followedprospectively by clinical assessment every 4 months for ayear to establish their respiratory and skin manifestations;at the third visit all children were evaluated by SPTs andspirometry, whereas 57 out of 69 underwent MCT to assess

BHR; 4 refused and 8 were unable to cooperate.Subjects, matched for age and sex with the study group,

with a negative history of food allergy in the first 3 yearsof life were selected from a general population sample of Athenian schoolchildren and assigned to two control groups.One consisted of 70 children sensitized to inhaled allergens

 D o w nl

 o ad

 ed 

 B y : [

 U ni

 v e r si

 t y 

 of 

 T o r o n t o] 

 A t : 21

 :20 1

 O c t ob

 e r 2008

592   K. N. PRIFTIS ET AL.

Page 40: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 40/83

TABLE 2.—Clinical characteristics of study group in the first 3 years of life; the OR (95% CI) refers to sensitized only to egg and only to fish subjects.

Total

N = 69∗Sensitised only

to egg N = 40

Sensitised only

to fish N = 9   OR (95% CI)

Mean age at diagnosis of sensitisation (mo) 20.6± 10.3 19.5 ± 10.5 21.2 ± 3.6 0.97 (0.89–1.05)Mean age at first clinical presentation (mo) 10.7± 4.3 10.1 ± 5.2 12.4 ± 3.6 1.15 (0.97–1.37)Presenting symptoms (%)

Urticaria/anaphylaxis 46 (66.6) 29 (74.4) 7 (77.8) 0.77 (0.14–4.07)Atopic dermatitis 30 (43.5) 16 (40.0) 2 (22.2) 0.48 (0.07–3.32)Gastrointestinal symptoms 12 (17.3) 5 (12.5) 4 (44.4) 5.83 (1.0–33.77)¶

Respiratory distress 7 (10.3) 3 (7.5) 2 (22.2) 1.52 (0.11–20.76)Sensitisation to other food allergens (%) 43 (62.3) 15 (37.5) 8 (88.9)¶ 13.9 (1.48–131.17)

Milk 11 (15.9) 6 (15.0) 1 (11.1) 0.45 (0.02–8.34)Nuts 16 (23.2) 4 (10.0) 6 (66.5)# 66 (3.89–1146.47)Cereals 12 (17.4) 4 (10.0) 1 (11.1) 1.07 (0.08–13.41)Shellfish 8 (11.6) 1 (2.5) 4 (44.4)# 43 (2.84–674.90)Fruits 9 (13.0) 2 (5.0) 2 (22.2) 4 (0.32–42.83)Vegetables 6 (8.7) 3 (7.5) 1 (11.1) 1.08 (0.07–15.65)

Sensitisation to inhaled allergens (%) 41(59.4) 20 (50.0) 4 (44.4) 0.81 (0.13–4.94)

Mites 18 (26.1) 8 (20.0) 0 NAMolds 10 (14.5) 5 (12.5) 0 NAPollen 28 (40.5) 13 (32.5) 4 (44.4) 1.9 (0.26–14.82)Pets 13 (18.8) 12 (30.0) 1 (11.1) 0.22 (0.02–2.74)

∗20 cases were sensitized to both egg and fish protein; NA=non applicable.¶ p < 0.05;  # p < 0.01.

exact test was performed for categorical variables; Student’st or Mann-Whitney U tests were suitable for continuous para-metric and non-parametric variable. The characteristics of 

children of the primary study group, i.e., sensitized to hen’segg versus fish protein at presentation, were compared sepa-rately and odds ratios with 95% confidence interval (CI) werecalculated.Logistic regression analysis wasused to assess theindependent effects of various risk factors (maternal smoking,atopic family history, wheezing in infancy, sensitization to in-haled or food allergens allergens, current or lifetime asthmasymptoms, chronic rhinitis, and atopic dermatitis) on BHR.Significance was two tailed and set at   p ≤ 0.05.

RESULTS

The main characteristics of the study population (studygroup, controls) are presented in Table 1. Atopic familyhistory, lifetime asthma symptoms, lifetime-current chronicrhinitis and lifetime atopic dermatitis reported by studygroup differed significantly from non-sensitized controls;current asthma symptoms were reported significantly morefrequently in the study group than in either control groups.Current atopic dermatitis was found to be more frequentin sensitized   versus   study group and non-sensitized con-

TABLE 3.—Sensitization to inhaled and/or food allergens at school-age in study group and sensitized controls.

Study group

Sensitised controls

Sensitized only to egg N = 40 Sensitized only to fish N = 9 OR (95% CI) Total N = 69* N = 70 OR (95% CI)

trols. Seventeen (56.7%) current asthmatics of study groupand 4 (23.5%) of sensitized controls were on mainte-nance anti-asthma treatment (OR 0.23, 95%CI 0.06-0.89,

 p = 0.04).The presenting symptoms were reactions to relevant food

in 45 (65.2%) children of thestudygroup. Theclinical charac-teristics ofthe 69children in the first 3 years of life are shownin Table 2. Sixty-two (89.8%) presented with skin manifesta-tions (atopic dermatitis and/or urticaria) and 29 (42.0%) re-ported wheezing before 3 years of age, which was associatedto sensitization to inhaled allergens by that time ( p = 0.001).

At school age, 38 (63.3%) cases had developed tolerance toegg and were able to consume it freely; the one child that re-

tained positive SPT for egg was also able to consume it freelyas well. The median age of egg tolerance was 2.1 (1.0-7.4)years. Ten outof 29 (34.5%) children lost their sensitizationtofish but only 5 (17.2%) of these children developed tolerance;however, tolerance to fish occurred at a significantly older ageas compared to egg, i.e., 5.0 (2.5–8.2) years ( p = 0.004).

The prevalence of sensitization to inhaled and food aller-gens during school age in the study group and sensitized con-trols is shown in Table 3. Sensitization to molds was detected

 D o w nl

 o ad

 ed 

 B y : [

 U ni

 v

 e r si

 t y 

 of 

 T o r o n t o] 

 A t : 21

 :20 1

 O c t ob

 e r 2008

FOOD ALLERGY, ASTHMA AND BRONCHIAL REACTIVITY 593

Page 41: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 41/83

TABLE 4.—Spirometry (mean ± SD) and BHR in the three groups of the study.

Study group

N = 69*

Sensitised controls

N = 70

Non-sensitised

controls N = 84

FVC (% predicted) 94.5± 8.2 96.2 ± 9.1 99 ± 6.6FEV1  (% predicted) 98.4± 8.3 99.3 ± 7.2 97.7 ± 7.1FEF50 (% predicted) 87.7± 16.9 75.9 ± 16.5 83 ± 10.6Positive metacholine 31 (54.4)# 28 (40.0)# 8 (9.5)challenge test (%)

∗Methacholine bronchial challenge test performed in 57 out of 69 children.¶ In comparison to either study group or non-sensitized controls:  p < 0.01.#In comparison to non-sensitized controls:  p < 0.001.

more frequently in the study group than among sensitizedcontrols.

All children of the study group exhibited normal pul-monary function tests (Table 4). A significant decrease of MEF50 values was detected among controls sensitized to in-haled allergens as compared to the study group. Multivariateanalysis of spirometric indices and specific sensitization re-vealed an independent association of sensitisation to miteswith MEF50 values (OR: 0.97, 95%CI: 0.95-1.0,   p = 0.04).

Study group showed a significantly increased frequency of positive response to MCT when compared with the controlsas a whole (OR: 0.26, 95%CI: 0.13-0.49,   p < 0.001); the

difference was statistically insignificant when study groupsseparatelywere compared with the sensitizedcontrol subjects(OR: 0.56, 95%CI: 0.28–1.12,   p = 0.07).

The results of multivariate logistic regression analysis be-tween BHR and current asthma symptoms (dependent vari-ables) in the index case group and relevant clinical charac-teristics of children during infancy and school age (indepen-dent variables) are presented in Table 5. BHR was associated

TABLE 5.—Multivariate logistic regression analysis (95% CI) between BHR andcurrent asthma (dependent variables) and various characteristics of study group

(independent variables).

Current

Variables

BHR OR

(95% CI)

asthma

OR (95% CI)

Atopy family history 2.52 (0.34–21.47) 3.05 (0.57–15.89)Pa ssive smoking 0.21 (0.02–2.06) 2.86 (0.50–16.12)Urticaria/anaphylaxis in

infancy0.65 (0.19–2.25) 0.40 (0.07–2.37)

Atopic dermatitis in infancy 1.57 (0.50–4.88) 2.10 (0.43–10.6)

Gastrointestinalmanifestations in infancy 2.2 (0.50–0.56) 1.2 (0.28–5.7)

Wheezing in infancy 12 (1.40–103.63)∗ 15.18 (2.62–94.23)#

Current eczema 2.23 (0.11–44.37) 1.47 (0.11–19.35)Current rhinitis 0.45 (0.04–4.33) 2.09 (0.44–9.83)Lifetime asthma symptoms 0.41 (0.01–9.92) 23.27 (2.35–241.62)#

Current asthma symptoms 51.42 (2.34–1105.31)∗ NASensitization to perennial in

infancy13.3 (2.9–59.8)# 12.5 (2.6–60.2)#

with wheezing andsensitization to perennial allergens (mites,molds) in infancy as well as in school age; it was also associ-ated with early sensitization to inhaled allergens (OR: 13.24,95%CI: 1.76-85.20,   p < 0.01). There was no association toanaphylaxis at presentation, persistence of sensitization toegg/fish or development of tolerance.

DISCUSSION

The present case control study of infants allergic to eggand/or fish followed to school age demonstrates that they areat increased risk of wheezing illness and BHR at school age.Diagnosis of childhood asthma and airway hyperreactivity isassociated with early sensitization to inhaled allergens and

late sensitization to mites and molds; conversely, they are notassociated with atopic dermatitis of infancy or retention of food allergy into school age.

Our results confirm the transient character of egg allergyand are in agreement with the findings of others that sen-sitization to hen’s egg in infancy is a marker of increasedrisk of sensitization to inhaled allergens and asthma symp-toms later in life (6, 20). In the Isle of Wight birth cohortstudy, allergy to egg, whether during infancy or cumulative,correlated with respiratory allergic symptoms (asthma and/or

rhinitis) and sensitization to aero-allergens at 4 years of age(6). In the GermanMulticenter Allergy Study (MAS) childrenwith a long-lasting sensitization to food allergens developedallergic rhinitis or allergic asthma more often than childrenonly transiently or never sensitized to food (20). In contrastto MAS we found that asthma symptoms as well as BHRwere not associated with retention of egg or fish allergy. Thisdifference could be due to methodological issues; the MASstudy investigated sensitized children regardless of clinicalexpression and did not differentiate in its analysis between

the various food allergens; thus its findings do not take intoaccount differences in the natural history of allergic diseasecaused by different food allergens. However, these reports(6, 20) did not include follow-up into school age. It is of interest that when the MAS cohort was reviewed at 7 yearsof age, children with early atopic dermatitis and concomi-tant wheeze carried an almost threefold higher risk of havingcurrent wheeze; this effect was independent of concurrentsensitization to egg or milk (21).

According to our findings the prevalence of current asthma

symptoms as well as BHR was higher in the index case groupas compared to the control group; the difference in BHRdid not reach significance when compared to controls sensi-tized to inhaled allergens, but there was an apparent trendtowards higher prevalence in study group. However, con-trol group as a whole is a general population sample with

 D o w nl

 o ad

 ed 

 B y : [

 U ni

 v

 e r si

 t y 

 of 

 T o r o n t o] 

 A t : 21

 :20 1

 O c t ob

 e r 2008

594   K. N. PRIFTIS ET AL.

Page 42: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 42/83

exposures to environmental factors are more likely to havea greater impact on the immature immune system and air-ways and the subsequent development of disease (22). Ini-tial assault may be sensitization to food allergens, clinicalmanifestation of atopic dermatitis, wheezing illness, or evensensitization to inhaled allergens.

The earliest serologic marker for atopic immunoreactiv-ity in infancy is the presence of IgE antibodies to egg, fol-lowed by milk (8), with an estimated point prevalence of allergy to egg of 1.6% in children 2.5 years of age (23). In aBritish population-based birth cohort study (ALSPAC) 0.4%of children skin prick tested at approximately 7.5 years werepositive to egg (24). A strong association between sensitiza-tion to egg and sensitization to aeroallergens, such as grass

or tree pollen and mites, was found in the ALSPAC study;unfortunately, no information on the clinical presentation of sensitized children was reported (24).

We found that development of BHR in symptomatic infantsallergic to egg and/or fish in infancy is not associated withatopic dermatitis either in infancy or in school age. Most stud-ies use the outcome of atopic dermatitis as the “entry point”of subsequent allergic disease that is often accompanied byfood allergy (3, 11, 21, 25). However, there are data that sup-port the hypothesis of two or more variants of eczema that

carry different prognoses and disease associations (26–29).Our finding of an association between BHR and sensitizationto inhaled allergens but not to atopic dermatitis supports thishypothesis. It seems that a genetic background that facili-tates a specific immune response constitutes the main drivethat determines the manifestations of the allergic march (11);this genetic background may not be present in all cases of the“atopic eczema/dermatitis syndrome.”

We found different patterns in the natural history of egg ascompared to fish allergy; however, sensitization to hen’s egg

or fishat schoolage didnot constituteindependentrisk factorsof BHR or current asthma symptoms in school age (Table 5).Specific sensitization to food depends on the specific allergencharacteristics, degree of utilize,and host characteristics (30).Conversely, while the development of BHR is also related toexposure, adjuvant factors, and host characteristics (31, 32),ourresults suggest that it most likely is unrelated to the naturalhistory of food allergy.

Lung function measurements revealed lower air flows atmid-FVC of controls sensitized to inhaled allergens as com-

pared to the study group and non-sensitized controls; thiscould be the result of inhaledmaintenance treatment of symp-tomatic children. Sensitization to mites was associated withlower FEF50 values. A negative association between FEV1 orFEF50 and sensitization to house dust mite has been reportedpreviously (33).

(14, 15). A negative history of food allergy by 3 years of age in control groups may be subject to recall bias. To mini-mize this possibility parents were interviewed personally byone of the study’s physicians (A.P.); despite this limitation,the low prevalence of food allergy in the general population(34) makes it highly likely that such bias only minimally af-fected our results. Lastly, we recognize that a small numberof children exclusively allergic to fish represent a limitationof the study but we were not able to obtain more cases mono-sensitized to fish up to 3 years of age.

In conclusion, the findings of our study show that childrenwho had egg or fish allergy in infancy have an increased risk for asthma symptoms and hyperreactive airways in schoolage as compared to their non-allergic peers. Late wheezing

or BHR is mostly determined by wheezing and sensitizationto inhaled allergens in early life and is not associated with themanifestation of atopic dermatitis in infancy or persistenceof egg or fish allergy until school age.

REFERENCES

1. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006;

355:2226–2235.

2. AsherMI, MontefortS, BjorkstenB, LaiC, StrachanD, Weiland S, Williams

H; ISAAC Phases Three Study Group. Worldwide time trends in the preva-

lence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema

in childhood: ISAAC Phases One and Three repeat multicountry cross-

sectional surveys. Lancet 2006; 368:733–743.

3. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma

in infantsand young childrenwith atopic dermatitis – a prospective followup

to 7 years of age. Allergy 2000; 55:240–245.

4. HalkenS. Prevention of allergicdisease in childhood: clinicaland epidemio-

logical aspects of primary and secondaryallergyprevention. Pediatr Allergy

Immunol 2004; (15 suppl )16:9–32.

5. Nickel R, Kulig M, Forster J, Bergmann R, Bauer C, Lau S, Guggenmoos-

Holzmann I, WahnU. Sensitisation to hen’segg at theage of twelve monthsis predictive for allergic sensitization to common indoor and outdoor aller-

gens at the age of three years. J Allergy Clin Immunol 1997; 99:613–617.

6. TariqSM, Matthews SM,Hakim EA,Arshad SH.Egg allergy in infancypre-

dicts respiratory allergic disease by 4 yearsof age. Pediatr AllergyImmunol

2000; 11:162–167.

7. Kawamoto N, Kaneko H, Takemura M, Seishima M, Sakurai S, Fukao

T, Kasahara K, Iwasa S, Kondo N. Age-related changes in intracellular

cytokine profiles and Th2 dominance in allergic children. Pediatr Allergy

Immunol 2006; 17:125–133.

8. Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U. Natural

course of sensitization to food and inhalant allergens during the first 6 yearsof life. J Allergy Clin Immunol 1999; 103:1173–1179.

9. Togias A. Systemic effects of local allergic disease. J Allergy Clin Immunol

2004; 113(1 suppl):S8–S14.

10. Peters S. The impact of comorbid atopic disease on asthma: clinical expres-

sion and treatment. J Asthma 2007; 44:149–161.

11. Wahn U. What drives the allergic march? Allergy 2000; 55:591–599.

 D o w nl

 o ad

 ed 

 B y : [

 U ni

 v

 e r si

 t y 

 of 

 T o r o n t o] 

 A t : 21

 :20 1

 O c t ob

 e r 2008

FOOD ALLERGY, ASTHMA AND BRONCHIAL REACTIVITY 595

Page 43: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 43/83

paper from the European Academy of Allergology and Clinical Immunol-

ogy. Allergy 2004; 59:690–697.

16. Standardization of spirometry: 1987 update. Statement of the American

Thoracic Society. Am Rev Respir Dis 1987; 136:1285–1298.

17. Quanjer PhH. Standardized lung function testing. Bull Eur Physiopathol

Respir 1983; 19(suppl 5):45–51.18. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG,

MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish

JE, Sterk PJ. Guidelines for methacholine and exercise challenge testing-

1999. Thisofficialstatementof the American Thoracic Society was adopted

by the ATS Boardof Directors, July 1999. Am J RespirCritCareMed 2000;

161:309–329.

19. Dreborg S, Backman A, Basomba A, BousquetJ, DiegesP,Malling H. Skin

tests used in type I allergy testing. Position paper, prepared by the subcom-

mittee on skin prick tests within the European Academy of Allergology and

Clinical Immunology. Allergy 1984; 44(suppl 10):1–59.

20. Kulig M, BergmannR, Tacke U, Wahn U, Guggenmoos-HolzmannI. Long-lasting sensitization to food during the first two years precedes allergic

airway disease. The MASStudy Group, Germany. Pediatr AllergyImmunol

1998; 9:61–67.

21. IlliS, von MutiusE, Lau S,Nickel R,Gruber C, NiggemannB, WahnU, the

Multicenter Allergy Study Group. The natural course of atopic dermatitis

from birth to age 7 years and the association with asthma. J Allergy Clin

Immunol 2004; 113:925–931.

22. Huang SW. Follow-up of children with rhinitis and cough associated with

milk allergy. Pediatr Allergy Immunol 2007; 18:81–85.

23. Eggesbø M,Botten G,Halvorsen R.,Magnus P. Theprevalenceof allergy to

egg:a population-basedstudy in young children. Allergy2001:56:403–411.

24. Roberts G, Peckittw C, Northstonez K, Strachan D, Lack G, Henderson J,

Golding J and the ALSPAC Study Team. Relationship between aeroaller-

gen and food allergen sensitization in childhood. Clin Exp Allergy 2005;

35:933–940.

25. Ricci G, Patrizi A, Baldi E, Menna G, Tabanelli M, Masi M. Long-term

follow-up of atopic dermatitis: Retrospective analysis of related risk factors

and association with concomitant allergic diseases. J Am Acad Dermatol

2006; 55:765–771.26. Flohr C, Johansson SGO, Wahlgren CF, Williams HC. How “atopic” is

atopic dermatitis? J Allergy Clin Immunol 2004; 114:150–158.

27. Kusel MM, Holt P, de Klerk N, Sly P. Support for 2 variants of eczema. J

Allergy Clin Immunol 2005; 116:1067–1072.

28. Lowe AJ, Hosking CS, Bennett CM, Carling JB, Abramson MJ, Hill DJ,

Dharmage SC. Skin prick test can identify eczematous infants at risk of 

asthma and allergic rhinitis. Clin Exp Allergy 2007; 37:1624–1631.

29. van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young

children with atopic eczema: a systematic review. J Allergy Clin Immunol

2007; 120:565–569.

30. Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitiv-ities.J Allergy Clin Immunol 2005; 115:3–112.

31. Sears MR, Burrows B, Herbison GP, Holdaway MD, Flannery EM. Atopy

in childhood. II. Relationship to airway responsiveness, hay fever, and

asthma.Clin Exp Allergy 1993; 23:949–956.

32. Bergren DR. Tobacco smoke is an adjuvant for maintained airway sensiti-

zation in guinea pigs. J Asthma 2007; 44:723–728.

33. Anthracopoulos M, Mantzouranis E, Paliatsos A, Tzavelas G, Lagona

L, Nicolaidou P, Priftis K. Different effects of sensitization to mites

and pollens on wheezing and spirometry in children: a population-

based cohort study. Ann Allergy Asthma Immunol 2007; 99:122–

129.

34. Høst A. Adverse reactions to foods: epidemiology and risk factors. Pediatr

Allergy Immunol 1995; 6(suppl 8):20–28.

 D o w nl

 o ad

 ed 

 B y : [

 U ni v

 e r si

 t y 

 of 

 T o r o n t o] 

 A t : 21

 :20 1

 O c t ob

 e r 2008

 Acta Pædiatrica IS SN 0803–5253

Page 44: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 44/83

R E G U L A R A R T I C L E

Neonatal characteristics and risk of atopic asthma in schoolchildren:

results from a large prospective birth-cohort studyUrsula Kiechl-Kohlendorfer ([email protected])1, Elisabeth Horak 2, Wilfried Mueller3, Robert Strobl4, Claudia Haberland5,Franz-Martin Fink 6, Michaela Schwaiger6, Karl-Heinz Gutenberger7, Hannes Reich7, Dagmar Meraner2, Stefan Kiechl8

1.Department of Paediatrics, Division of Neonatology, Neuropaediatrics and Metabolic Diseases, Innsbruck Medical University, Innsbruck, Austria2.Department of Paediatrics, Division of Paediatric Cardiology and Pulmonology, Innsbruck Medical University, Innsbruck, Austria3.Department of Paediatrics, Reutte County Hospital, Reutte, Austria4.Department of Paediatrics, Lienz County Hospital, Lienz, Austria5.Department of Paediatrics, Kufstein County Hospital, Kufstein, Austria6.Department of Paediatrics, St. Johann County Hospital, St. Johann, Austria7.Department of Paediatrics, St. Vincent’s Hospital , Zams, Austria

8.Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

Keywords

Atopic asthma, Children, Farming, Hospitalization,Risk factors

Correspondence

Ursula Kiechl-Kohlendorfer, Department of Paediatrics, Division of Neonatology,Neuropaediatrics and Metabolic Diseases,Innsbruck Medical University, Anichstrasse 35,6020 Innsbruck, Austria.

Tel.: +43 512 504 23600 |Fax: +43 512 504 23484 |

Email: [email protected]

Received

18 May 2007; revised 3 July 2007; accepted 6 July2007.

DOI:10.1111/j.1651-2227.2007.00449.x

Abstract

Aim: Asthma is among the most common chronic diseases in childhood and steadily increasing in

prevalence. Identification of risk predictors for a hospitalization for atopic asthma in childhood may

help design prevention programmes and improve our understanding of disease pathobiology.

Methods: An ongoing birth-cohort study prospectively enrolled all liveborn infants in Tyrol. Between

1994 and 1999 baseline data were collected for 33 808 infants. From 2000 to 2005, all children

hospitalized for atopic asthma at an age of 6 years or over (n = 305) were identified in a careful

search of hospital databases. Disease status was ascertained from the typical medical history, athorough examination and proof of atopy.

Results: Male sex (relative risk 2.11, 95% CI 1.65–2.70), urban living environment (vs. rural) (1.93,

1.47–2.54), neonatal admission to hospital (1.70, 1.20–2.40), lack of breastfeeding (1.32,

1.02–1.70), postnatal smoking (1.31, 1.00–1.72) and low birth weight (1.45, 0.94–2.23) all

emerged as adverse risk predictors for hospitalization for atopic asthma whereas a low risk was found

among children living on a farm (0.22, 0.05–0.87) and children with two to three siblings (vs. no or

one sibling) (0.71, 0.51–0.97).

Conclusion: In this study a number of neonatal characteristics and environmental exposures were associated

 with hospitalization for atopic asthma in childhood, suggesting that early life is crucial for disease determination

and lending further indirect support to the hygiene hypothesis.

INTRODUCTION

Asthma is among the most common chronic diseases in

childhood and imposes an increasing economic and health

 burden (1). Previous studies have suggested that factors

acting early in life and even in the prenatal period may

predispose to or render individuals resistant to childhood

asthma (2,3). In addition, birth characteristics and sociode-

mographic variables like birth weight (4,5), sex (6,7), family

size (8) and parental educational level (9) have been linked

to the risk of asthma manifestation and hospitalization, but

the available results are not entirely consistent In the last

studies may deepen our understanding of disease pathobi-

ology and provide a basis for prevention strategies aimed at

counteracting the steadily increasing burden of asthma (14).

The current study will investigate the association of neonatal

and environmental characteristics with hospitalization for

atopic childhood asthma in a large prospective birth-cohortstudy (n = 33808).

PATIENTS AND METHODS

Study area

The survey area of this study is Tyrol a federal state in the

Kiechl-Kohlendorfer et al.   Neonatal characteristics and risk of atopic asthma

Page 45: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 45/83

and another 2.1% moving within the Tyrol still contributing

to the group of hospitalized asthmatics.

Study population and clinical characteristics

Data on pregnancy, birth and neonatal characteristics wereprospectively collected 4–6 weeks after birth for all infants

liveborn between April 1994 and December 1999 (n   =

45 642). The participation rate was high at 74.1% (n   =

33808).

The following variables were assessed by means of a stan-

dardized questionnaire completed by the infant’s mother:

(a) infant’s data: age, sex, birth weight and gestation (<37

and  ≥   37 weeks); (b) sociodemographic background: mar-

ital status, educational level and profession of the parents;

(c) pregnancy characteristics: mother’s age at delivery, num-

 ber of previous pregnancies and deliveries, maternal smok-

ing habits during pregnancy and after birth of the child;

(d) postnatal factors: neonatal hospitalization, child care

practices such as the usual sleeping position and feeding

practices; (e) place of residence. The questionnaire used in

the current study is part of the public health programme in

Tyrol and was approved by the appropriate committee of 

the local Board of Health. Categorization of all variables

was prespecified. Low birth weight was defined by a cut-off of   <2500 g. Season of birth was categorized as ‘cold

months’ (November–February) or ‘other months’. Feeding

practice during the first 4–6 weeks of life was coded ‘breast-

fed’ if the main type of milk given was breast milk. Parental

educational level was documented in years of education

(<12 years, 12 years,and>12 years). A farming environment

was assumed if farm work was given as a full-time occu-

pation. Living environment was coded ‘urban’ (large towns

with>

100 000 inhabitants), ‘suburban’ (towns with 10 000–100 000 inhabitants), or ‘rural’ (villages with <100 00 inhab-

itants).

 Ascertainment of asthma cases

Data on hospitalization for atopic asthma of children aged

6–10 years (born April 1994 to December 1999) were ex-

tracted from computer databases of all children’s hospitals

in Tyrol. Children aged 5 years and under were not included

in the current investigation, because there are many differ-

ent causes for wheezing in this age range. In a first step,

a search was made for diagnoses 493.0 (ICD-9) and J45.0

(ICD-10) which identified 721 infants. In a second step the

diagnosis was confirmed by two paediatric pulmonologists

(E.H., D.M.) based upon a critical review of the hospital

medical records A diagnosis of asthma required a medi-

The level of specific IgE was measured by radioallergo sor-

 bent assay (RAST) and considered elevated if the level was

≥   3.5 kU per litre for the specific allergen. A total of 367

(50.9%) out of 721 children satisfied these criteria.

Statistical analysis

Data analysis was performed using SPSS 12.0 for Windows.

Associations between categorized baseline variables and

hospitalization for atopic childhood asthma were analyzed

with the   2 test. Relative risks were estimated from logis-

tic regression analysis applying hospitalization for asthma as

the dependent variable. Models were fitted with a forward-

stepwise selection procedure (probability values for entry

and removal of variables, 0.10 and 0.15) and variables se-lected for inclusion from all those listed in Table 1. The

test procedure was based on maximum-likelihood estima-

tors, and the goodness of fit of each model was assessed

 by the test of Hosmer and Lemeshow. Differential associa-

tions in subgroups were tested by the inclusion of interaction

terms. All p-values were two-sided.

RESULTS

A critical review of hospital admission records identified 367children with atopic asthma in the survey area, who required

at least one hospitalization in the period between 2000 and

2005. Neonatal questionnaires had been returned in 305 of 

the cases.

Descriptive characteristics of the overall birth cohort

(33 808) are shown in Table 1.

Univariate analysis showed hospital admission for asthma

to be significantly associated with male sex, low birth weight,

urban living environment, parental educational level, neona-tal admission to hospital, lack of breastfeeding and smoking.

Detailed analyses indicated that the increase in asthma

risk equally applied to women who smoked during and after

pregnancy (n  =  4645, RR [95% CI] 1.36 [1.01–1.84]) and

those who abstained during pregnancy but restarted smok-

ing after delivery (n = 1445, RR [95% CI] 1.57 [0.98–2.52])

whereas the number of women who smoked during preg-

nancy and quitted thereafter was too low to assess reliable

risk estimates (n = 259).

In addition, the risk for hospitalization for atopic asthma

was lower in children who live on a farm and those having 2–

3 siblings, and in children of parents with a low education

level. In detail, relative risks of asthma amounted to 1.00,

0.71 and 1.25 for children with 1, 2–3 and 4 siblings when

compared with those without a sibling Finally there were

 Neonatal characteristics and risk of atopic asthma   Kiechl-Kohlendorfer et al.

Page 46: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 46/83

Table 1  Association of neonatal, sociodemographic and environmental charac-

teristics with hospitalization for atopic childhood asthma (n = 38 808)

Hospitalizations Frequency of 

Subjects for asthma hos pita lizations

 Variable at risk per 1000 PYs∗ p-value‡

Sex

Male 17 219 210 6.3   <0.001

Female 16 589 95 3.0

Season of birth

Cold months 10 126 92 4.8 0.935

Other months 23 682 213 4.6

Birth weight

<2500 g 1666 26 8.4 0.004

≥2500 g 32 142 279 4.5

Mother’s age at delivery

<23 years 3886 33 4.2 0.711

≥23 years 19 922 272 4.7

Number of siblings

≤1 sibling 25 655 248 5.0 0.028

2 or 3 siblings 7171 46 3.3

≥4 siblings 982 11 5.7

Single parenthood

No 30 381 278 4.8 0.455

Yes 3427 27 3.6

Educational level†

<12 years 22 032 163 4.3 0.042

12 years 4012 45 6.8

≥12 years 4441 38 5.1

Farming

No 32 658 303 4.8 0.004

Yes 1150 2 1.0

Living environment

Urban 4186 70 8.1   <0.001

Suburban 4010 24 3.3

Rural 25 612 211 4.2

Neonatal admission to hospital

No 31 269 263 4.3   <0.001

Yes 2539 42 8.7

Initial breast feeding

No 4580 54 6.0 0.033Yes 29 228 251 4.4

Prone sleeping position

No 32 071 289 4.7 0.932

Yes 1737 16 4.1

Postnatal smoking

Table 2   Multivariate association between risk variables and hospitalization for

atopic childhood asthma (n = 33 808)

 Variable RR (95% CI) p value

Male sex 2.11 (1.65–2.70)  <

0.001Living environment   <0.001

Rural 1.00

Suburban 0.70 (0.46–1.07) 0.097

Urban 1.93 (1.47–2.54)   <0.001

Neonatal admission to hospi tal 1.70 (1.20–2.40) 0.003

Farming 0.22 (0.05–0.87) 0.032

Lack of breastfeeding 1.32 (1.02–1.70) 0.034

Postnatal smoking 1.31 (1.00–1.72) 0.048

Number of siblings 0.058

≤1 sibling 1.00

2 or 3 siblings 0.71 (0.51–0.97) 0.033

≥4 siblings 1.26 (0.68–2.31) 0.462

Low birth weight 1.45 (0.94–2.23) 0.091

Relative risks (RR) and 95% confidence intervals (95% CI) were es-

timated from logistic regression analysis. The multivariate analysis was

fitted with a forward-stepwise selection procedure allowing for all variablesin Table 1 (probability values for entry and removal of variables, 0.10 and 0.15).

level lost significance after inclusion of smoking and lack of 

 breastfeeding. The risk profiles identified were virtually iden-

tical in boys and girls and subgroups according to different

level of parental education.

DISCUSSION

This prospective population-based study identified a numberof significant risk predictors for hospitalizations because of 

atopic childhood asthma (Tables 1 and 2). Some of the as-

sociations have been described in previous birth cohorts fo-

cusing on asthma manifestation or hospitalization (9,11,15–

18), whereas others like a farming environment have not

yet been addressed in prospective studies. Notably, the bulk

of risk predictors were neonatal characteristics indicating

that early life is crucial for the determination of childhood

asthma. The positive association with postnatal smoking and

urban living environment indicates a detrimental effect of 

in- and outdoor air pollution on asthma manifestation and

course, while the strong inverse association with the number

of siblings (surrogate for microbiological burden) and living

on a farm and in a rural environment may be considered

further support for the hygiene hypothesis (8 10)

Kiechl-Kohlendorfer et al.   Neonatal characteristics and risk of atopic asthma

d th i k f i f ti i d d i b t ti (19) f ilit t th d l t f i t ill (25) d

Page 47: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 47/83

reduces the risk of infection-induced airway obstruction (19)

andhas profound effects on the infant’s intestinalmicroflora,

and anti-inflammatory as well as immunomodulatory prop-

erties (20). The higher risk for asthma among low birth

weight infants is in accordance with previous studies (4,21)and probably results from irreversible constraints in airway

development (21) and subsequent small airway size (22).

The majority (80%) of the neonatal hospital admissions in

our cohort were due to respiratory distress, and this was es-

pecially true for preterm infants. Therefore, the increased

risk for severe asthma with subsequent hospitalization in

this group might be explained by chronic lung disease, as

commonly observed in premature neonates, and/or by lung

injury after mechanical ventilation. There is evidence that in-

fants who survive a respiratory distress syndrome and those

with a lower than normal lung function are at greater risk for

developing respiratory disease in later life (23). Vice versa, a

family history of asthma (genetic predisposition) was shown

to increase the risk for severe neonatal respiratory distress

leading to hospital admission (24).

As anticipated, environmental exposure early in life may

interfere in the maturing immune system and play a crucial

role in the development and course of atopy and asthma.

An effective innate immune system (involving its signallingpathways), induction of a profound shift in the TH1/TH2

 balance towards TH1 preponderance and more complex

changes in immune responsiveness like the development of 

immune tolerance and subtle modifications in TH2 response

are considered protective against atopy and asthma (11–13).

The type and amount of allergens, window of allergen con-

tact and associated circumstances (e.g. level of airway in-

flammation) may determine whether exposure causes sensi-

tization or immune tolerance. Early exposure to infectionstransmitted by contact with older siblings has repeatedly

 been related to a decreased risk for atopic disease (8,11). This

theory, first postulated by Strachan in the 1980s, was termed

the hygiene hypothesis (10). Lifestyle changes in western

society, especially the decreasing number of children in a

family, may well have contributed to the increase in allergic

diseases. The current study provides further evidence that a

larger number of siblings may afford protection against the

development of severe asthma leading to hospitalization, but

this finding does not extend to families with four and morechildren. Observation of a protective effect of farming in our

study is in accordance with a few cross-sectional evaluations

(12,13).

Early-life contact with microbial compounds that are

highly prevalent on farms may account for this phenomenon

se facilitates the development of respiratory illness (25) and

promotes sensitization to environmental allergens and may

trigger severe asthma attacks. Analogue effects have to be as-

sumed for indoor exposure to tobacco smoke. Actually, the

results of the current study support the notion that parentalsmoking is an important determinant of atopic asthma in

children (16,26).

Apart from inducing airway inflammation and priming

sensitization (27), smoking impairs lung development and

function in utero and in the postnatal period (28).

Merits and limitations The main merits of our study are

its prospective design and size (n  =   33 808). Size clearly

exceeds that of comparable birth-cohort studies focusing

on neonatal characteristics, most of which included a few

thousand infants (9,11,15–18). Furthermore, ascertainment

of asthma did not rely on the parents’ responses to the

questionnaire or the patient’s self-report but on a thorough

in-hospital examination by a specialist in paediatric pul-

monology. In each case the diagnosis was confirmed by

proof of atopy (positive skin-prick test reaction to common

aeroallergens and/or increased specific IgE levels). There

are limitations as well. Firstly, this study was primarily de-

signed to assess risk factors for sudden infant death syn-

drome (SIDS) and apparent life-threatening event (29,30)and later extended to childhood asthma. Accordingly, some

variables meaningful for the current analysis like family his-

tory of asthma and pet contact were not systematically as-

sessed. Secondly, the focus on asthma hospitalization does

ultimately not allow to differentiate whether risk predictors

are related to asthma manifestation or exacerbation. In this

context it should also be mentioned that in Tyrol health

care is free of charge and easily accessible throughout the

survey area and does not differ between sociodemographicgroups, making confounding by selective hospital admission

unlikely. Finally, a minor proportion of families moved out

of the survey area during the study period (1.2% per year).

Because these families do no longer contribute to the pop-

ulation of hospitalized asthmatics relative risks in Table 2

may be modestly underestimated.

In conclusion, our study identifies a broad array of neona-

tal and environmental risk predictors for hospitalization for

atopic asthma in childhood, suggesting that disease man-

ifestation and expression is in part determined early inlife, and provides further indirect support to the hygiene

hypothesis.

ACKNOWLEDGEMENTS

The questionnaire used in the current study is part of

 Neonatal characteristics and risk of atopic asthma   Kiechl-Kohlendorfer et al.

3 Strachan DP Is allergic disease programmed in early life? Clin for asthma from childhood to young adulthood: a

Page 48: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 48/83

3. Strachan DP. Is allergic disease programmed in early life? Clin

Exp Allergy 1994; 24: 603–5.4. Svanes C, Omenaas E, Heuch JM, Irgens LM, Gulsvik A. Birth

characteristics and asthma symptoms in young adults: resultsfrom a population-based cohort study in Norway. Eur Respir J 

1998; 12: 1366–70.5. Shaheen SO, Sterne JAC, Montgomery SM, Azima H. Birth

weight, body mass index and asthma in young adults.  Thorax

1999; 54: 396–402.6. Osman M. Therapeutic implications of sex differences in

asthma and atopy. Arch Dis Child 2003; 88: 587–90.7. Wever-Hess J, Kouwenberg JM, Duiverman EJ, Hermans J,

Wever AMJ. Risk factors for exacerbations and hospitaladmissions in asthma of early childhood. Pediatr Pulmonol

2000; 29: 250–6.8. Strachan DP. Family size, infection and atopy: the first decade

of the “hygiene hypothesis.” Thorax 2000; 55: 2–10.9. Hancox RJ, Milne BJ, Taylor DR, Greene JM, Cowan JO,

Flannery EM, et al. Relationship between socioeconomicstatus and asthma: a longitudinal cohort study.  Thorax 2004;59: 376–80.

10. Strachan DP. Hay fever, hygiene and household size. Br Med J 

1989; 299: 1259–60.11. Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ,

Martinez FD, Wright AL. Siblings, day-care attendance, andthe risk of asthma and wheezing during childhood. N Engl J 

Med 2000; 343: 538–43.12. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M,Grize L, et al. Environmental exposure to endotoxin and itsrelation to asthma in school-age children.  N Engl J Med 2002;347: 869–77.

13. Riedler J, Braun-Fahrl ander C, Eder W, Schrever M, Waser M,Maisch S, et al. Exposure to farming in early life anddevelopment of asthma and allergy: a cross-sectional survey.Lancet 2001; 358: 1129–33.

14. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP,Weiland SK, et al. Worldwide time trends in the prevalence of 

symptoms of asthma, allergic rhinoconjunctivitis, and eczemain childhood: ISAAC Phases One and Three repeatmulticountry cross-sectional surveys. Lancet 2006; 368:733–44.

15. Rothenbacher D, Weyermann M, Beermann C, Brenner H.Breastfeeding, soluble CD 14 concentration in breast milk andrisk of atopic dermatitis and asthma in early childhood: birthcohort study. Clin Exp Allergy 2005; 35: 1014–21.

16. Kull I, Almqvist C, Lilja G, Pershagen G, Wickman M.Breast-feeding reduces the risk of asthma during the first 4years of life.  J Allergy Clin Immunol 2004; 114: 755–60.

17. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, et al. Risk factors for hospital admission

for asthma from childhood to young adulthood: alogitudinal population study.  J Allergy Clin Immunol 2002;110: 220–7.

18. Hagendorens MM, Bridts CH, Lauwers K, van Nuijs S, EboDG, Vellinga A, et al. Perinatal risk factors for sensitization,

atopic dermatitis and wheezing during the first year of life(PIPO study). Clin Exp Allergy 2005; 35: 733–40.

19. Friedman NJ, Zeiger RS. The role of breast-feeding in thedevelopment of allergies and asthma.   J Allergy Clin Immunol

2005; 115: 1238–48.20. Hoppu U, Kalliomaki M, Laiho K, Isolauri E. Breast

milk-immunomodulatory signals against allergic diseases. Allergy 2001; 56: 23–6.

21. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD,Shaheen SO. Relation of birth weight and childhoodrespiratory infection to adult lung function and death fromchronic obstructive airway disease. Br Med J  1991; 303:671–5.

22. Inselman LS, Mellins RB. Growth and development of thelung. J Pediatr  1981; 98: 1–15.

23. Haland G, Lodrup Carlsen KC, Sandvik L, Devulapalli CS,Munthe-Kaas MC, Morten Pettersen MD, et al. Reduced lungfunction at birth and the risk of asthma at 10 years of age. N 

Engl J Med 2006; 355: 1682–9.24. von Mutius E, Nicolai T, Martinez FD. Prematurity as a risk

factor for asthma in preadolescent children. J Pediatr  1993;

123: 223–9.25. D’Amato G, Liccardi G, D’Amato M. Environmental riskfactors (outdoor air pollution and climatic changes) andincreased trend of respiratory allergy. J Investig Allergol Clin

Immunol 2000; 10: 123–8.26. Lau S, Nickel R, Niggemann B, Gruber C, Sommerfeld C, Illi

S, et al. The development of childhood asthma: lessons fromthe German Multicentre Allergy Study (MAS). Paediatr Respir 

Rev  2002; 3: 265–72.27. Ronchetti R, Macri F, Ciofetta G, Martinez FD. Increased

serum IgE and increased prevalence of eosinophilia in 9 year

old children of smoking parents. J Allergy Clin Immunol 1990;86: 400–7.

28. Tager IB, Weiss ST, Munoz A, Rosner B, Speizer FE.Longitudinal study of the effects of maternal smoking onpulmonary function in children. N Engl J Med 1983; 309:699–703.

29. Kiechl-Kohlendorfer U, Pupp Peglow U, Kiechl S, OberaignerW, Sperl W. Epidemiology of sudden infant death syndrome(SIDS) in the Tyrol before and after an intervention campaign.Wien Klin Wochenschr  2001; 113: 27–32.

30. Kiechl-Kohlendorfer U, Hof D, Pupp Peglow U, Traweger-

Ravanelli B, Kiechl S. Epidemiology of apparent lifethreatening events. Arch Dis Child 2005; 90: 297–300.

Page 49: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 49/83

From:

Epidemiology: An Introduction

Kenneth J. Rothman

Oxford University Press

2002

ISBN 0-19-513554-7

 

Page 50: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 50/83

Page 51: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 51/83

Page 52: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 52/83

 

 

Page 53: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 53/83

Page 54: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 54/83

Page 55: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 55/83

Page 56: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 56/83

 

 

Page 57: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 57/83

Page 58: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 58/83

 

 

Page 59: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 59/83

Page 60: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 60/83

Page 61: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 61/83

 

Page 62: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 62/83

Page 63: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 63/83

 

Page 64: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 64/83

 

Page 65: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 65/83

 

Page 66: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 66/83

 

Page 67: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 67/83

 

 

From:

Epidemiology: An Introduction

Kenneth J. Rothman

Oxford University Press, 2002

ISBN 0-19-513554-7

Page 68: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 68/83

Page 69: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 69/83

 

Page 70: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 70/83

Page 71: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 71/83

 

Page 72: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 72/83

 

Page 73: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 73/83

 

 

Page 74: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 74/83

Page 75: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 75/83

 

Page 76: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 76/83

 

Page 77: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 77/83

 

ir  =

s;s

v+s

=

5

Z

-O

=c-

F H 

6r

:H

t

e E

s

,3tS

E

,a

S

3iS

Page 78: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 78/83

I

.-ia

 

ra

 v

a

-

OJ

-

'-o-qO

lrO

'b

o

.aE

E

-5

+

+

+s

=(

.

g

l

c

-aP

o

f5

0

Iq'dF

\.hEG

a

O

E

-cJ

5

c

Se-nC

d

>

e+

EE

:

:a

=

"

;

=E

-

"*e

eT

;

tr6

"E:X

-e

Y

q

jz

s

E

g

E

F

y2

55

=JEy

-

4

t eE

 F

8

$EEy

 .gH

 g

-*

 

Et€E

P

EscbF

:E

,Eo

E=

A

sFE?E;F

eE

€E+

E

Y

Ea

Z

;

;gH

E

-

*

E;z -P*(H

q

oo(g

.=i

I

rb=cZ

(aYF

" -

l g

=

' \

c

+<

^

F

(

l;Flp-\EX

 -v"99RA{)e.

aq

xv=

T

*a

I

-

JFu

vor

^

ca.9

R

aE6F

4

r

;z\

t=

v-

/<4=

r

v

X\JO4U

q(aqO*6-(U+

+Ft

t=:3YaCafoO

-K=^5aaP9=f=YfSUl{ac

ai

.=z9.oPa

o

.c?hYho

-e*?-Z-

.=\

n

cqz3r

{8q

Page 79: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 79/83

.ar(---

t

a

lr

'(J

i

-+

q

l-

R

L

l-

-

O

:J

*?t5q.H

+

-2-

E

q

C-dp

dE

c

F

.=

(

q2

#

:

 

'

-

 Y

I

h

s

)

q

=

.Z^

s-

1

-

t

;

-

iJ

ia

Sa

 

r

.=E

),g

G

't=

F

_

o

a

=

:1

 

q

a

f

-

F

2

u

:-b

E"FE

5

:a

'l aE

E

.E

 

'A

1

q

 "a

II

E

a

tavJ=

l-E

A

'S*

,

l:

 )

|

=(

.?s

F

,

s

:r

'i;{Ar r

E

 : 

?

c: 

,1-y

++

y:

^

I

F=

 ,9

 F 

iz

x1

dt

3z

--

1

v

^1

i6

4

d

.3

i(

r

a

d

a

=

:1a

i

l

J

lr

:

c

tr

u

=

v

t-I+

*e

9.(a 9+Io

1-FqSIOC

C

a\E4\Gr 

bE

+r

F

nenX

t* 

i

af.v-O+I4"u+I

=EU

z=2Ea9.(o

cV

(

y

EcJE=2A

==E?ECt9

.?

E

IE E

f i

c a

*z

c=

2

+

2

jr

:=

o

(

a

f9

-

=5

+

J

6=

€E

;

*

{

;3

=

"

=E

c

i\

l=S

=+A 

*+

H

la

X-

i-c

2=

,

,d

' a

-

t

tu

t

I+9

h

v=

{u

{?

sE

<

=

q

q

s?3

sisea

g

I g

a

"a>

v*

-c

'E

a=I

6

.

1

-

--d(Jo

4

g

C

(r

*>o

d

G

c

C

a3O

ocO'6

:-

t

'YO

q

b3

aF

i

4

d

L7

rc::

F

c.

IcJ

.

.

4E

-L"e

:.

c

=

n

'4rZ

dEs

.=

-

\

-J

+

L

*

cE

 

1

=

\<7

a

a

=Uo

rVP

.?=

L

.u

=2

-_

t+D

{

Y

-

=

.JZ

c

'

6

,

-

u

\E

d

u

G

=

-c9

iAa

i

c

c

_

L

\

Os

"

.

.P

F

=J

=

.Le

CvZ>

%

;

d

9Y-

 

-c

d

F-o

-

-L

u

-9

:

uEyZ

n^

Page 80: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 80/83

 

eF

:  I

{

I iE

s

 igg

E

 i;  l

 :

ifg

| | 

g

sj 

l Ez  g

g

 

gE

O

V

s

rcr

1E=

3

; €E;:n=

iIB 

E E

E

F

iF: 

q

sr 

g:rE

E

}Eg

f

i;e

E*?

as

r-gE

Eg

g

+F

Vc

Oot>>a

AzL

O

a@

oi>F=E(

OzL

O

a

 tttIal,=a.

a

>

rXa1H\

>oE

^

.

a

F

hi>;Er

4\

z>o

=

:

@

IS

SO

OA

Soo

oo

OUacqtIt

FF

E

lo'aK"<

F

LU

c

Y3

#U

:^

:adF=zA

LU_u

:?

ir

u

=

o@*

*6C

a*>tYrEkn

I

JZ

A

L

U

.

e

v

E+

RYY

V

(

IS ^-s

v

Page 81: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 81/83

==

E

>cJu

c

c

b

-1o

=,=.=

E

=

:1=n

*-FE

9=

.E

I

-

_

=

=

-=

=E

.=

.y 

itzz7

't+

-E

c=EE=

fr4

i" 

E

=

z

3=

4

s&=e

IGo

Q

&

ErI=

E

 {_

=

c

;-E

i>a

a

,1

E

dF

-==

io-cS

-c=

E

=

a=F

zE.

==

hE:9

T

a

Y

E

E

=

'r2

-=dE

"=

==

?c-

 7

.S-=>

>)

'=

3

eX

q

.

I

o

o

83- 6E

E-o

Hg

5E

-d

S

ifE

2z7Y

e

==

' -E

6 -E>

y 54

9

oc

9UHo

oE>-o

g

r?>

f.Je

E

 

?=

"q:

n

 .=

 

-

o

:

ad

JP

A

-

1

c

h^

"

@ Q

q*

 

=

=

.=I3

1

Z-Ee

5E3

-d=^=w

?

B

3

4

=

u"=

'=

-=

luE

-EZ

o

i=E

=FE

 B

.2

;=

s:*.

E

t€F=

e

(o

=

i =9=r

Jb

F-FE

"<

E

F=

-

IcPF?P

^a

aA

.€

63

A

5

Qc

;uX

rn

>1\

:

;-":u1

0O

l

gH

:

X

J

o

c4aF

c

g

A

UE

o

t,n<>Uz>

a

n

O

S--SO

<E+

znn

gs>a.=

=

E

;E

;e;gE

;FE

r

qa

e€5t

?

E3E:rE

: -

=*i

P

E

y=e

=E

f=5

:sg

+Z

f  f g

 iE

 F

s€

sgEEtE

E

 

svEE

+?

=

 teIE

E€

rc;E z

E

EE

gEE E

++

d

J

nv

^-COu oc

dt

"odaac

6

lsloo

tH?

lE

sq

lf

E

le

 g

I

EE

lr

o

lF#S

IXE

lFI$FB

:B5O

E

[S

F

E

=Q

h

>

E

 

,

s,"X

q

:*HX

;?

t

EXd

5

g

F

'5

e&

qo

c<

Page 82: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 82/83

>

>

.9Rqa6u->qEO

JoS9

EEU

C+>a

qx

F

c

c

s'Eq-,Ou9

-F

H

v=O

H

Cv

-F=-AvA*ELA

:4

)

R

L

r

=

l

F8

N

Uq

fn

d

9(J

c

a

9-.

.u

qo*U

9U

L

vF

q+e .

aP

IrFF

$

Nra{q(h

I

t?r=

)XI c

2 +

HAYFH

*

J

io\o\ol

H

r5+

V

O

o

X{L(

.

c

roqr

V

€o

hA

rc\+

oIIJV

L^

V-

QvE

va

a

.

c

>'=.=c

-e

--9

tR

F

'

-

t

R

9v

*P

-a

e

-

s=

2

J6

-C

a

a

S

P

=

;

;

'-

34

o

i =eS-

9

-Ez:

O

':

=

t=

C

sB9

-

-4=

d

-v

X

E

4

d_h:3

a>5E

<

Aa

n5Y

';1>8

>

-Y+

A

-

e

co

 >9=

:Le

vTO

-cctsK

=o

iv

dX9rE

 

-d 

i

o-o

93

EA

tF

i-=at=,f*a

i-

S

 sa,O.=,ob

u

.

a<

^

E6

:oo.EadF.9a-a

Ecc

nU;U;>=QUa

2u

l

a4fN

wN

Page 83: GREAT Lecture1 Epid Study Design Handout

8/13/2019 GREAT Lecture1 Epid Study Design Handout

http://slidepdf.com/reader/full/great-lecture1-epid-study-design-handout 83/83

*a

7a

.=d

&

7

-a=

L

L

==Y

99

p

n

2

9

=

r

c

C

;

a

-

v

-

-

4

&

ta

-

Y

,

-

,e

-c=

a?u

=

e

9

3^

:

^

i=n

i

-=:3

-

-Q

="

i

?

t

 Y

9

)

-_-=_

i=

}1

L

tQ

n^7

P

z+

23€6

F

M

=

Y

>

^

2

t=

-

ia<

E

??

;=.E

_

3

t

;Lo

1=

ipE.?c

_YL

r9

=

I2

Y

"A

.

Y

9

.=

iZi

E

2z=Y

=r1

-

;-=7

=

994^

d

c

-

O

Y

C

'.2

L

-

.2F=E

4

,4

=

 

-CZ

i

'a

a

=fr

a

14=t

rt 

:=-

'=-

?o

E

=

P

XF

c

 

'

'

J

-

-

oL-

oQ

n

u

#+

rn

'o

L

.=-

dDF

m

f(

rc

(+

+d

Irn

s

C

E

F

 ;E

Edd

?

Z=,rE

*;F?

E:aE

E Ecr

-

5 ti :2E

(P

o

E

OA

E

= a

1F

tn*

E;F3E

EFP

FYE

-E

=c

-opc

=?

c

p

V

-y

i=

-

:;#aE

E

E

:E

:r6

;

EF

E

rr,

H

 E

E

+C

E

n

:E

se€

e

:eE;

c E-a

; :

f*E

E€:z

t

fE ;g

E+9*tE

9

E=

=E

 

;dE

E-E

:€Er=t$E3

:=7

i=E

€d

;e

s

eE

=E

ed

eE

 

Egg aA

 Z

uuE

Ei i

rnA;

L

= a=

x>

U-

u

-=

ugu*

P

*

lLC

gS

g